Learn more

SANOFI AVENTIS

Overview
  • Total Patents
    8,983
  • GoodIP Patent Rank
    125,041
  • Filing trend
    ⇧ 100.0%
About

SANOFI AVENTIS has a total of 8,983 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 1984. It filed its patents most often in Argentina, Taiwan and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are VERTEX PHARMACEUTICALS INC CAM, LY TAI WEI and VERTEKS FARMAS JUTIKALZ INKORPOREJTED.

Patent filings per year

Chart showing SANOFI AVENTISs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Casellas Pierre 333
#2 Evanno Yannick 320
#3 Lochead Alistair 290
#4 Barth Francis 278
#5 Rinaldi-Carmona Murielle 261
#6 Dubois Laurent 256
#7 Saady Mourad 243
#8 Congy Christian 241
#9 Yaiche Philippe 233
#10 Jegham Samir 223

Latest patents

Publication Filing date Title
AU2014271291A1 Fgf-r4 receptor-specific antagonists
AU2013209322A1 Novel anti-cd38 antibodies for the treatment of cancer
AU2011204768A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors
TW201215387A Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201212920A Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
EP2532755A1 Methods and uses based on Slfn2 expression and relating to the identification and profiling of compounds for use in the treatment or prevention of pain
TW201206910A Substituted N-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof
FR2974576A1 N - [(1H-PYRAZOL-1-YL) ARYL] -1H-INDOLE OR 1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS
TW201141513A Insulin-siRNA conjugates
TN2011000153A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cylophosphamide
WO2011121223A1 6-(alkyl- or cycloalkyl-triazolopyridazine-sulfanyl) benzothiazole derivatives: preparation, application as medicaments and use as met inhibitors
FR2973027A1 Process for the synthesis of cetobenzofuran derivatives
FR2972629A1 PACKAGING FOR UNITARY PHARMACEUTICAL PRODUCTS
US2011207811A1 Use of celivarone for reducing occurrences of cardiovascular hospitalization
TN2011000046A1 Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack
FR2970969A1 Oligosaccharides 3-o-alkyl activators of fgfs receptors, their preparation and their therapeutic application
TN2011000029A1 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
TW201130802A Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
TW201136940A Carboxylic acid derivatives comprising a 2,5,7-substituted oxazolopyrimidine ring
TW201141873A 2,5,7-substituted oxazolopyrimidine derivatives